Back to companies

BioNTech SE: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on BioNTech SE’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into BioNTech SE's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Helmut Jeggle

Chairman Executive Board Since: 2008 Age: 55

Mr. Helmut Jeggle has been the Chairman of the company since 2008. He also serves as the Chief Executive Officer at Salvia GmbH. Prior to this, he served as the Head of Direct Investments of ATHOS Service GmbH from 2007 to 2015. Previously, he served as the Head of Business Planning & Analyses at Hexal AG from 2002 to 2007.

Read Hide full bio of Helmut Jeggle

Ugur Sahin, M.D.

Chief Executive Officer Senior Management Since: 2008 Age: 60

Mr. Ugur Sahin has been the Chief Executive Officer of the company since 2008. Prior to this, he served as a Professor (W3) in Translational Oncology & Immunology at Johannes Gutenberg University. Previously, he served as the Chairperson of the Scientific Management Board at the Helmholtz Institute for Translational Oncology.

Read Hide full bio of Ugur Sahin, M.D.

Ramon Zapata-Gomez

Chief Financial Officer Senior Management Since: 2025 Age: 52

Mr. Ramon Zapata-Gomez has been the Chief Financial Officer of the company since 2025. Prior to this, he served as the Chief Financial Officer and Head of Scientific Operations of BioMedical Research at Novartis.

Read Hide full bio of Ramon Zapata-Gomez

Sierk Poetting

Chief Operating Officer Senior Management Since: 2014 Age: 53

Mr. Sierk Poetting has been the Chief Operating Officer of the company since 2014. Prior to this, he served as the Vice President and Chief Financial Officer of the Sandoz Division at Novartis from 2012 to 2014.

Read Hide full bio of Sierk Poetting

James Ryan

Chief Business Officer; Chief Legal Officer Senior Management Since: 2023 Age: 50

Mr. James Ryan has been the Chief Legal Officer and Chief Business Officer of the company since 2023. Prior to this, he served as the General Counsel and Senior Vice President of Legal and IP of the company. Previously, he served as the Head of Legal Affairs at legal group of GW Pharmaceuticals.

Read Hide full bio of James Ryan
Gain a 360-degree view of BioNTech SE and make more informed decisions for your business Gain a 360-degree view of BioNTech SE and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer